Jeffrey T L Smith
CIK 1604800 · EVP & Chief Medical Officer · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$876.0K
Companies
2
Total Filings
46
Lifetime Open-Market Net
-$7.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZYME | EVP & Chief Medical Officer | 36,018 | $24.32 | $876.0K | -$641.4K | 5 | 2026-01-12 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Managing Director | 5,272 | — | — | -$6.92M | 36 | 2019-09-18 |
Recent Filings · Page 2 of 5
46 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-09-18 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$467.6K | EDGAR |
| 2019-04-25 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | +4,441 | -$66.5K | EDGAR |
| 2019-02-08 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-04 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$64.8K | EDGAR |
| 2018-11-05 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$62.6K | EDGAR |
| 2018-10-03 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$73.3K | EDGAR |
| 2018-09-06 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$85.7K | EDGAR |
| 2018-08-02 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$93.5K | EDGAR |
| 2018-07-03 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$171.6K | EDGAR |
| 2018-06-05 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$200.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.